S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Investors Eye July 27 Deadline in AeroVironment Securities Lawsuit

Investors who purchased AeroVironment, Inc. securities between June 25, 2025, and March 10, 2026, face a critical July 27, 2026, deadline to seek lead plaintiff status. The Rosen Law Firm is currently spearheading the class action litigation, which alleges the company misled shareholders regarding competitive threats to its key military contracts.

Investors Eye July 27 Deadline in AeroVironment Securities Lawsuit
Photo: Bio & News

The lawsuit centers on claims that AeroVironment failed to disclose the true extent of competition for work involving the U.S. Space Force’s Satellite Communication Augmentation Resources program and the modernization of the Satellite Control Network. According to the complaint, these omissions led to an inflated outlook on the company's financial prospects. Once the competitive reality became public, shareholders reportedly suffered significant losses.

Those who incurred losses exceeding $100,000 are being encouraged to step forward as lead plaintiffs to help direct the litigation. Rosen Law Firm, which is managing the case, notes that no class has been certified yet. Investors are not required to take action to remain potential class members, though those wishing to influence the legal proceedings must file their motions with the court by the late July cutoff. The firm operates on a contingency fee basis for this matter, meaning participants do not pay out-of-pocket costs.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!